相似文献
1
Effectiveness of spironolactone for women with acne vulgaris (SAFA) trial: a critically appraised topic.
Br J Dermatol. 2023 Oct 25;189(5):509-510. doi: 10.1093/bjd/ljad270.
2
Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Cochrane Database Syst Rev. 2003(4):CD000194. doi: 10.1002/14651858.CD000194.
3
Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Cochrane Database Syst Rev. 2001(4):CD000194. doi: 10.1002/14651858.CD000194.
4
Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Cochrane Database Syst Rev. 2000(2):CD000194. doi: 10.1002/14651858.CD000194.
5
Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult women.
BMJ Open. 2021 Aug 26;11(8):e053876. doi: 10.1136/bmjopen-2021-053876.
6
Cost-effectiveness of Spironolactone for Adult Female Acne (SAFA): economic evaluation alongside a randomised controlled trial.
BMJ Open. 2023 Dec 11;13(12):e073245. doi: 10.1136/bmjopen-2023-073245.
7
Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Cochrane Database Syst Rev. 2009 Apr 15(2):CD000194. doi: 10.1002/14651858.CD000194.pub2.
8
Spironolactone and cimetidine in treatment of acne.
Acta Derm Venereol. 1988;68(1):84-7.
9
Oral spironolactone: an effective treatment for acne vulgaris in women.
Br J Dermatol. 1986 Aug;115(2):227-32. doi: 10.1111/j.1365-2133.1986.tb05722.x.
10
FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial.
Trials. 2020 Jun 25;21(1):571. doi: 10.1186/s13063-020-04432-w.
引用本文的文献
1
Oral and topical spironolactone in acne treatment: A meta-analysis of effectiveness and safety.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan 29. doi: 10.1007/s00210-025-03840-6.
本文引用的文献
1
Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial.
BMJ. 2023 May 16;381:e074349. doi: 10.1136/bmj-2022-074349.
2
Long-term use of spironolactone for acne in women: A case series of 403 patients.
J Am Acad Dermatol. 2021 May;84(5):1348-1355. doi: 10.1016/j.jaad.2020.12.071. Epub 2021 Jan 9.
3
Use of spironolactone to treat acne in adolescent females.
Pediatr Dermatol. 2021 Jan;38(1):72-76. doi: 10.1111/pde.14391. Epub 2020 Oct 3.
4
Trends in Oral Antibiotic Prescription in Dermatology, 2008 to 2016.
JAMA Dermatol. 2019 Mar 1;155(3):290-297. doi: 10.1001/jamadermatol.2018.4944.
5
Approaches to limit systemic antibiotic use in acne: Systemic alternatives, emerging topical therapies, dietary modification, and laser and light-based treatments.
J Am Acad Dermatol. 2019 Feb;80(2):538-549. doi: 10.1016/j.jaad.2018.09.055. Epub 2018 Oct 5.
6
Frequency of Treatment Switching for Spironolactone Compared to Oral Tetracycline-Class Antibiotics for Women With Acne: A Retrospective Cohort Study 2010-2016.
J Drugs Dermatol. 2018 Jun 1;17(6):632-638.
7
Trends in prescribing behavior of systemic agents used in the treatment of acne among dermatologists and nondermatologists: A retrospective analysis, 2004-2013.
J Am Acad Dermatol. 2017 Sep;77(3):456-463.e4. doi: 10.1016/j.jaad.2017.04.016. Epub 2017 Jul 1.
8
Oral spironolactone improves acne vulgaris and reduces sebum excretion.
Br J Dermatol. 1984 Aug;111(2):209-14. doi: 10.1111/j.1365-2133.1984.tb04045.x.
Zotero 插件